More recently, agents such as semaglutide and liraglutide have received FDA approval for obesity treatment in individuals without diabetes, expanding on previous indications [1]
TCM has been widely used in the treatment of various clinical diseases
These medications are typically injected, which presents additional challenges when it comes to packing, transporting, and administering them while traveling
Ipamorelin stands out as a highly selective ghrelin mimetic
evidence limited to preclinical animal and in vitro studies Semaglutide : Three FDA approvals across diabetes, obesity, and oral delivery
Future research should deepen our understanding of the dietary requirements of people with obesity that are undergoing treatment with GBT and future nutrient stimulated hormone therapies that produce similar changes in dietary intake and body weight